Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Athersys logo — Committed to developing therapies to extend and enhance the...

Athersys

Committed to developing therapies to extend and enhance the quality of life.

Founded 1995 United States Cleveland, United States 37 employees Post Ipo Equity Total: $208.90M Biopharma, Biotechnology +2

General Information

Company Name Athersys
Founded Year 1995
Location United States Cleveland, United States +1
Founders / Decision Makers
Team member
Employees 37
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post Ipo Equity
Social

Get notified when Athersys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Athersys

Athersys is a biopharmaceutical company committed to developing therapies to extend and enhance the quality of life. Established in 1995 and headquartered in the United States, Athersys focuses on the discovery and development of innovative medicines to treat significant and life-threatening diseases. The company's pipeline of potential best-in-class therapeutics includes stem cell therapy and pharmaceuticals, employing proprietary technologies. Recently, Athersys secured a $3.70M Post-IPO Equity investment on 18 April 2023, showcasing ongoing support for its advancements in the field of biopharma, biotechnology, healthcare, and life sciences. With a promising future, Athersys stands as a compelling prospect for potential investors in the healthcare sector.

Taxonomy: biopharmaceutical, therapeutics, clinical stage, drug development, regenerative medicine, stem cell therapy, pharmaceuticals, innovation, disease indications, clinical trials, proprietary technologies, life-threatening diseases, quality of life, multi-disease indications

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 18 Apr 2023
Post-IPO Equity •••••• - 09 Nov 2022
Post-IPO Equity •••••• - 15 Aug 2022
Post-IPO Equity •••••• - 20 Apr 2020
Post-IPO Equity •••••• - 02 Feb 2017

View All 9 Funding Rounds

Athersys Alternatives & Competitors

Athersys vs
InMed Pharmaceuticals
InMed Pharmaceuticals Canada

Global leader in the manufacturing and development of rare cannabinoids. Our subsidiary is Baymedica...

Post Ipo Equity
18 employees
Biotechnology, Health Care
Compare Athersys vs InMed Pharmaceuticals
Athersys vs
Plexxikon Inc.
Plexxikon Inc. United States

Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of nov...

Series B
15 employees
Biotechnology, Health Care
Compare Athersys vs Plexxikon Inc.
Athersys vs
CHAIN Biotechnology Ltd
CHAIN Biotechnology Ltd United Kingdom

Superior and effective microbiome therapeutics

Seed
8 employees
Biotechnology, Health Care
Compare Athersys vs CHAIN Biotechnology Ltd

FAQ About Athersys

Committed to developing therapies to extend and enhance the quality of life.
Athersys was founded in 1995.
Athersys is headquartered in Cleveland, United States.
Athersys operates in the following industries: Biopharma, Biotechnology, Health Care, Life Sciences.
Athersys has approximately 37 employees.
Athersys has completed 9 funding rounds, raising a total of $208.90M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Athersys include InMed Pharmaceuticals, Plexxikon Inc., CHAIN Biotechnology Ltd, Drug Discovery & Development, NeuroSense Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Athersys and InMed Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Athersys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy